// App-Quantinova.ai

DOP019 : Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

Researchers

Presenter

  • J Burisch

Principal Investigators

  • S Cukovic-Cavka

  • P L Lakatos

  • R D'Inca

  • F Magro

  • N Arebi

  • L Kievit

  • I Kaimakliotis

  • D Valpiani

  • K H Katsanos

  • Z Vegh

  • J F Dahlerup

  • M Fumery

  • N Pedersen

  • J Halfvarson

  • E Belousova

  • K R Nielsen

  • S Turcan

  • P Ellul

  • L Kupcinskas

  • P Oksanen

  • D Duricova

  • M Giannotta

  • A Goldis

  • V Hernandez

  • R Salupere

  • S Odes

  • E Langholz

  • P Munkholm

Medical Centers

  • North Zealand Hospital, Department of Gastroenterology, Frederikssund, Denmark

  • Viborg Regional Hospital, Medical department, Viborg, Denmark

  • Hospital of Southern Jutland, Medical Department, Aabenraa, Denmark

  • University Hospital Centre Zagreb, University of Zagreb School of Medicine, Division of Gastroenterology and Hepatology, Zagreb, Croatia

  • Semmelweis University, nd Department of Pathology, Budapest, Hungary

  • Azienda Ospedaliera di Paodva, Department of Sugery, Oncology and Gastroenterology, Padua, Italy

  • University of Porto, Institute for molecular and cell biology, Porto, Portugal

  • Hospital de Sao Joao, Department of Gastroenterology, Porto, Portugal

  • Oporto Medical School, Institute of Pharmacology and Therapeutics, Porto, Portugal

  • St Marks Hospital, Gastroenterology, London, United Kingdom

  • Herning Central Hospital, Department of Medicine, Herning, Denmark

  • Nicosia Private practice, Nicosia Private practice, Nicosia, Cyprus

  • Department of Gastroenterology and Digestive Endoscopy, E.O. Galliera Hospital, Genoa, Italy

  • University Hospital, Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece

  • Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark

  • Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France

  • Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark

  • Faculty of Medicine and Health, rebro University, Department of Gastronterology, rebro, Sweden

  • Moscow Regional Research and Clinical Institute (MONIKI), Department of Endocrine Surgery, Russian Federation

  • The National Hospital of the Faroe Islands, Medical Department, Thorshavn, Faroe Islands

  • State University of Medicine and Pharmacy of the Republic of Moldova, Department of Gastroenterology, Chisinau, Moldova, Republic of

  • Mater dei Hospital, Division of Gastroenterology, Msida, Malta

  • Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania

  • Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland

  • Charles University, IBD Center ISCARE, Prague, Czech Republic

  • AOU Careggi, Regional Referral Center fo Inflammatory Bowel Disease - Gastroenterology 1 Division, Florence, Italy

  • University of Medicine aVictor Babes?, Clinic of Gastroenterology, Timisoara, Romania

  • Complejo Hospitalario Universitario de Vigo, Gastroenterology, Vigo, Spain

  • Tartu University Hospital, Division of Endocrinology and Gastroenterology, Tartu, Estonia

  • Soroka Medical Center and Ben Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel

  • Gentofte Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark

Locations

  • Denmark

  • Croatia

  • Hungary

  • Italy

  • Portugal

  • United Kingdom

  • Cyprus

  • Greece

  • France

  • Sweden

  • Russia

  • Faroe Islands

  • Republic of South Korea

  • Malta

  • Lithuania

  • Czech Republic

  • Romania

  • Spain

  • Estonia

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved